'Best supportive care' has had its day
- 1 March 2001
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (3) , 173-175
- https://doi.org/10.1016/s1470-2045(00)00260-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Examining the benefits of chemotherapy in subgroups of patients with inoperable non-small cell lung cancerLung Cancer, 2000
- Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcomeBritish Journal of Cancer, 2000
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of LifeJournal of Clinical Oncology, 1999
- Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancerBMJ, 1999
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1991
- Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC' versus no treatmentEuropean Journal of Cancer and Clinical Oncology, 1988
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988